Previous 10 | Next 10 |
home / stock / ecl / ecl articles
Ecolab (NYSE:ECL) has outperformed the market over the past 20 years by 2.71% on an annualized basis producing an average annual return of 10.75%. ...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommends buying Abercrombie & Fitch Co. (NYSE:ANF). Abercrombie & Fitc...
HealthEquity (NASDAQ: HQY) recently announced the completion of the acquisition of Conduent's BenefitWallet Health Savings Account portfolio. I...
Koninklijke Philips (NYSE: PHG) notified its customers about a possible power malfunction in its Trilogy Evo continuous ventilators and initiated a...
FMC Corporation (NYSE: FMC) recently entered into a research partnership with AgroSpheres, a biotechnology firm dedicated to sustainable crop prote...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Cloudflare, Inc. (NYSE:NET) “right here.” The com...
Ecolab Inc. (NYSE:ECL) shares are gaining on Tuesday after the company reported first-quarter results. The company reported quarterly adj...
West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Con...
Ecolab (NYSE:ECL) has outperformed the market over the past 20 years by 2.82% on an annualized basis producing an average annual return of 10.47%. ...
News, Short Squeeze, Breakout and More Instantly...
DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the launch of a new investment fund to support businesses with the growth of emerging tools and technologies used in the bioprocessing of traditional mAbs and newer drug modalities. BioProcess360 Partners...
Ecolab Inc. (NYSE: ECL) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.2% on the day to $243.43. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internatio...
2024-07-08 06:00:05 ET Shlomo Rosenbaum from Stifel Nicolaus issued a price target of $283.00 for ECL on 2024-07-08 05:06:00. The adjusted price target was set to $283.00. At the time of the announcement, ECL was trading at $238.19. The overall price target consensus is ...